Stuart Black

2.2k total citations
9 papers, 1.2k citations indexed

About

Stuart Black is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Stuart Black has authored 9 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 2 papers in Cell Biology. Recurrent topics in Stuart Black's work include Cancer-related Molecular Pathways (6 papers), Cell death mechanisms and regulation (2 papers) and Adenosine and Purinergic Signaling (1 paper). Stuart Black is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), Cell death mechanisms and regulation (2 papers) and Adenosine and Purinergic Signaling (1 paper). Stuart Black collaborates with scholars based in United States, United Kingdom and Indonesia. Stuart Black's co-authors include Paul T. Kirschmeier, W. Robert Bishop, Hena R. Ashar, Suxing Liu, Asra Mirza, Luquan Wang, Qun Wu, Kimberly Gray, Donna Carr and Linda James and has published in prestigious journals such as Journal of Biological Chemistry, Nature Biotechnology and Oncogene.

In The Last Decade

Stuart Black

9 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stuart Black United States 9 921 637 140 117 108 9 1.2k
Sabine Brüsselbach Germany 16 702 0.8× 406 0.6× 185 1.3× 142 1.2× 132 1.2× 22 1.0k
Susan C. Evans United States 19 739 0.8× 265 0.4× 117 0.8× 128 1.1× 134 1.2× 28 1.1k
Teresa Petrocelli Canada 9 951 1.0× 534 0.8× 181 1.3× 186 1.6× 106 1.0× 11 1.4k
Jamie Bishop United States 7 808 0.9× 399 0.6× 142 1.0× 174 1.5× 135 1.3× 9 1.3k
Stephan Bergmann Germany 12 1.4k 1.5× 492 0.8× 163 1.2× 92 0.8× 204 1.9× 16 1.7k
Christel Guillouf France 19 1.3k 1.4× 767 1.2× 331 2.4× 123 1.1× 113 1.0× 32 1.6k
Crissy Dudgeon United States 14 760 0.8× 417 0.7× 192 1.4× 114 1.0× 107 1.0× 19 981
Haiyun Cheng United States 9 568 0.6× 472 0.7× 193 1.4× 98 0.8× 42 0.4× 12 944
Susan E. Morgan United States 9 860 0.9× 503 0.8× 243 1.7× 102 0.9× 48 0.4× 10 1.0k
Naomi Levy-Strumpf Israel 12 1.0k 1.1× 471 0.7× 151 1.1× 120 1.0× 80 0.7× 14 1.3k

Countries citing papers authored by Stuart Black

Since Specialization
Citations

This map shows the geographic impact of Stuart Black's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Black with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Black more than expected).

Fields of papers citing papers by Stuart Black

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Black. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Black. The network helps show where Stuart Black may publish in the future.

Co-authorship network of co-authors of Stuart Black

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Black. A scholar is included among the top collaborators of Stuart Black based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Black. Stuart Black is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Jha, Sharda, Erick J. Morris, Alan Hruza, et al.. (2016). Dissecting Therapeutic Resistance to ERK Inhibition. Molecular Cancer Therapeutics. 15(4). 548–559. 39 indexed citations
2.
Black, Stuart, Andrea Basso, Paul T. Kirschmeier, et al.. (2007). Enhancement of the antitumor activity of tamoxifen and anastrozole by the farnesyltransferase inhibitor lonafarnib (SCH66336). Anti-Cancer Drugs. 18(8). 923–931. 13 indexed citations
3.
McClanahan, Terrill K., Sandra Koseoglu, Eric A. Gustafson, et al.. (2006). Identification of overexpression of orphan G protein-coupled receptor GPR49 in human colon and ovarian primary tumors. Cancer Biology & Therapy. 5(4). 419–426. 150 indexed citations
4.
Mirza, Asra, Andrea Basso, Stuart Black, et al.. (2005). RNA interference targeting of A1 receptor-overexpressing breast carcinoma cells leads to diminished rates of cell proliferation and induction of apoptosis. Cancer Biology & Therapy. 4(12). 1355–1360. 68 indexed citations
5.
Mirza, Asra, Qun Wu, Hena R. Ashar, et al.. (2002). Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene. 21(17). 2613–2622. 462 indexed citations
6.
Wu, Qun, Paul T. Kirschmeier, Tong‐Yuan Yang, et al.. (2002). Transcriptional Regulation during p21/-induced Apoptosis in Human Ovarian Cancer Cells. Journal of Biological Chemistry. 277(39). 36329–36337. 88 indexed citations
7.
Ashar, Hena R., Linda James, Kimberly Gray, et al.. (2001). The Farnesyl Transferase Inhibitor SCH 66336 Induces a G2 → M or G1 Pause in Sensitive Human Tumor Cell Lines. Experimental Cell Research. 262(1). 17–27. 92 indexed citations
8.
Ashar, Hena R., Linda James, Kimberly Gray, et al.. (2000). Farnesyl Transferase Inhibitors Block the Farnesylation of CENP-E and CENP-F and Alter the Association of CENP-E with the Microtubules. Journal of Biological Chemistry. 275(39). 30451–30457. 261 indexed citations
9.
Porter, Ronald D., et al.. (1990). Use of the Escherichia coli ssb Gene to Prevent Bioreactor Takeover by Plasmidless Cells. Nature Biotechnology. 8(1). 47–51. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sabine Brüsselbach Breakdown of academic impact, for papers by Susan C. Evans Breakdown of academic impact, for papers by Teresa Petrocelli Breakdown of academic impact, for papers by Jamie Bishop Breakdown of academic impact, for papers by Stephan Bergmann Breakdown of academic impact, for papers by Christel Guillouf Breakdown of academic impact, for papers by Crissy Dudgeon Breakdown of academic impact, for papers by Haiyun Cheng Breakdown of academic impact, for papers by Susan E. Morgan Breakdown of academic impact, for papers by Naomi Levy-Strumpf
Rankless by CCL
2026